BRKR moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRKR as a result. In 69 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
The Moving Average Convergence Divergence Histogram (MACD) for BRKR turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The 10-day moving average for BRKR crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRKR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKR advanced for three days, in 200 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
BRKR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.578) is normal, around the industry mean (2.979). P/E Ratio (-79.900) is within average values for comparable stocks, (2.590). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (11.052). Dividend Yield (0.004) settles around the average of (0.009) among similar stocks. P/S Ratio (2.634) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. BRKR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The 10-day RSI Indicator for MASS moved out of overbought territory on October 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 23 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MASS as a result. In 80 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for MASS turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 43 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MASS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +2.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where MASS advanced for three days, in 221 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 106 of 132 cases where MASS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.753) is normal, around the industry mean (2.979). P/E Ratio (-12.116) is within average values for comparable stocks, (2.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (5.988) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. MASS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MASS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BRKR | MASS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 90 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 96 | |
PRICE GROWTH RATING 1..100 | 43 | 35 | |
P/E GROWTH RATING 1..100 | 99 | 93 | |
SEASONALITY SCORE 1..100 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BRKR's Valuation (9) in the Medical Specialties industry is in the same range as MASS (20) in the null industry. This means that BRKR’s stock grew similarly to MASS’s over the last 12 months.
BRKR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MASS (100) in the null industry. This means that BRKR’s stock grew similarly to MASS’s over the last 12 months.
BRKR's SMR Rating (92) in the Medical Specialties industry is in the same range as MASS (96) in the null industry. This means that BRKR’s stock grew similarly to MASS’s over the last 12 months.
MASS's Price Growth Rating (35) in the null industry is in the same range as BRKR (43) in the Medical Specialties industry. This means that MASS’s stock grew similarly to BRKR’s over the last 12 months.
MASS's P/E Growth Rating (93) in the null industry is in the same range as BRKR (99) in the Medical Specialties industry. This means that MASS’s stock grew similarly to BRKR’s over the last 12 months.
| BRKR | MASS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 64% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 74% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 80% |
| Advances ODDS (%) | 1 day ago 69% | 1 day ago 81% |
| Declines ODDS (%) | 7 days ago 74% | 13 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 74% | N/A |
| Aroon ODDS (%) | N/A | 1 day ago 80% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green while MASS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 3 TA indicator(s) are bullish while MASS’s TA Score has 3 bullish TA indicator(s).
BRKR (@Medical/Nursing Services) experienced а -0.46% price change this week, while MASS (@Medical/Nursing Services) price change was -4.80% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.88%. For the same industry, the average monthly price growth was -9.59%, and the average quarterly price growth was -10.00%.
BRKR is expected to report earnings on Nov 02, 2026.
MASS is expected to report earnings on Nov 09, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.
| Ticker / NAME | Correlation To BRKR | 1D Price Change % | ||
|---|---|---|---|---|
| BRKR | 100% | +1.01% | ||
| A - BRKR | 78% Closely correlated | +1.83% | ||
| MTD - BRKR | 75% Closely correlated | +0.51% | ||
| WAT - BRKR | 68% Closely correlated | +1.97% | ||
| RVTY - BRKR | 68% Closely correlated | +3.36% | ||
| TMO - BRKR | 66% Loosely correlated | +1.18% | ||
More | ||||
A.I.dvisor indicates that over the last year, MASS has been loosely correlated with PACB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MASS jumps, then PACB could also see price increases.
| Ticker / NAME | Correlation To MASS | 1D Price Change % | ||
|---|---|---|---|---|
| MASS | 100% | +0.70% | ||
| PACB - MASS | 46% Loosely correlated | +6.52% | ||
| TXG - MASS | 39% Loosely correlated | +2.25% | ||
| QSI - MASS | 39% Loosely correlated | +6.42% | ||
| BRKR - MASS | 37% Loosely correlated | +1.01% | ||
| TWST - MASS | 35% Loosely correlated | +2.10% | ||
More | ||||